Cargando…

Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19

BACKGROUND: Glomerular diseases (GD) are chronic conditions that often involve immune dysfunction and require immunosuppressive therapy (IST) to control underlying pathogenesis. Unfortunately, such diseases appear to heighten risks of severe outcomes in COVID-19 and predispose to other infections th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yeaman, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678218/ https://www.ncbi.nlm.nih.gov/pubmed/34935004 http://dx.doi.org/10.1159/000519182

Ejemplares similares

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression()
por: Cajamarca-Baron, Jairo, et al.
Publicado: (2021)

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease
por: Mackintosh, John A, et al.
Publicado: (2021)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
por: Liang, Hong-Yu, et al.
Publicado: (2022)

Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy
por: Diotallevi, Federico, et al.
Publicado: (2021)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation
por: Kim, Hye-Jin, et al.
Publicado: (2022)

Reinfection With SARS-CoV-2: Implications for Vaccines
por: Cohen, Jeffrey I, et al.
Publicado: (2020)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis
por: Kirchner, Theresa, et al.
Publicado: (2021)

Undetectable SARS-CoV-2 active adaptive immunity—post-vaccination or post-COVID-19 severe disease—after immunosuppressants use
por: Adedoyin, Oluwafeyi, et al.
Publicado: (2021)

Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
por: Ehianeta, Teddy, et al.
Publicado: (2021)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2022)

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
por: Higgins, Peter D R, et al.
Publicado: (2020)

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
por: Ward, Daniel, et al.
Publicado: (2022)

Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice
por: Paschall, Amy V., et al.
Publicado: (2022)

Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients
por: Zhang, Yue-Miao, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
por: Alexander, James L, et al.
Publicado: (2021)

SARS-CoV-2 infection in children and implications for vaccination
por: Nathanielsz, Jordan, et al.
Publicado: (2022)

COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer
por: King, Daniel A., et al.
Publicado: (2021)

Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2
por: Dhawan, Manish, et al.
Publicado: (2022)

COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination
por: Yang, Wan, et al.
Publicado: (2022)

Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines
por: Mukhopadhyay, Labanya, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
por: Lee, Jee-Soo, et al.
Publicado: (2022)

Mycotic clival osteomyelitis secondary to immunosuppression by SARS-CoV-2
por: Delgado-Arce, Julio César, et al.
Publicado: (2022)

Immunosuppression as a Hub for SARS-CoV-2 Mutational Drift
por: Shapira, Guy, et al.
Publicado: (2023)

SARS-CoV-2 rS (NVX-CoV-2373) vaccine for prevention of COVID-19
Publicado: (2022)

Vaccination Against SARS-CoV-2 in Immunosuppressed Patients with Rheumatic Diseases: Position Statement of the Greek Rheumatology Society
Publicado: (2020)

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Role of Immunosuppression on Efficacy of Anti-SARS-CoV-2 Vaccines in Heart Transplanted (HT) Patients
por: Masetti, M., et al.
Publicado: (2022)

SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
por: Lledó, Ana, et al.
Publicado: (2021)

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
por: Velikova, Tsvetelina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9920qdr95gpikjn3ko46nf7e6j